2015
DOI: 10.1074/jbc.m114.622217
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2

Abstract: Background: Modification of proteins with small ubiquitin-related modifier has many important functions in cell biology. Results: Substrate-attached SUMO chains are processed by the yeast enzymes Ulp1 and Ulp2 via different mechanisms. Conclusion: Ulp2 recognizes chains with three or more SUMO units and releases single SUMO molecules from their distal ends. Significance: Ulp2 controls the dynamic length range of cellular SUMO chains.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
13
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 65 publications
2
13
0
Order By: Relevance
“…Thus, Ulp2's C-terminal SIM helps it to preferentially cleave longer SUMO chains, most likely via its increased binding affinity to longer SUMO chains. Our finding here is consistent with a prior study showing that Ulp2 preferentially cleaves longer SUMO chains in vitro (38). However, we have…”
Section: Sumo Binding Mediates Ulp2 Substrate Specificitysupporting
confidence: 94%
“…Thus, Ulp2's C-terminal SIM helps it to preferentially cleave longer SUMO chains, most likely via its increased binding affinity to longer SUMO chains. Our finding here is consistent with a prior study showing that Ulp2 preferentially cleaves longer SUMO chains in vitro (38). However, we have…”
Section: Sumo Binding Mediates Ulp2 Substrate Specificitysupporting
confidence: 94%
“…Large amounts of high molecular weight (HMW) SUMO conjugates, which accumulate in the stacker of SDS-PAGE gels, are observed in ulp2D cells. Correspondingly, Ulp2 has a preference in vitro for cleaving between SUMO monomers in polySUMO chains (Hickey et al 2012;Eckhoff and Dohmen 2015). The identities of most of the HMW-SUMO conjugates are unknown, as is their contribution to the growth defects of ulp2D cells (Bylebyl et al 2003).…”
mentioning
confidence: 99%
“…The in vitro results are well consistent with the in vivo observation ( Figure 3B), and thus eliminated the possibility of two-hybrid false positive. Combined, the results suggested by, 2006; Eckhoff & Dohmen, 2015;Park et al, 2011;Yang, Hsu, Ting, Liu, & Hwang, 2006). In addition, human SUMO2 and SUMO3 formed chains in vitro and in vivo, primarily through a conserved acceptor, Lys11 (Park et al, 2011;Tatham et al, 2001).…”
Section: Rin13 Was Sumoylated By Sumo1 2 3 and 5 In E Coli Sumoylamentioning
confidence: 64%